Company Overview and News
Japan's Nikkei share average rose on Friday morning after the European Central Bank announced it would avoid raising rates until mid-2019, but chip-related stocks tumbled after a brokerage slashed the target price of Tokyo Electron.
4503 ALPMY ADTTF ALPMF MRAAF MRAAY 8035 TOELF ATEYY TOELY
The semiconductor industry has been red hot this year, up 16.5% as a whole versus 4% for the S&P 500. Top industry players like Micron Technology (MU - Free Report) and Nvidia (NVDA - Free Report) have gotten the lion’s share of the attention from investors – and rightfully so as they have performed even better than the industry.
HD CREE MU VSH CSX NVDA 8035 TOELF YY TOELY
The 225-issue Nikkei average lost 227.77 points, or 0.99 percent, to close at 22,738.61 on the Tokyo Stock Exchange. On Wednesday, the key market gauge rose 88.03 points.
8035 TOELF TOELY
A company’s ability to provide good returns to its investors even after meeting all its business-related costs and expenses can be measured using profitability analysis. A fundamentally strong company generally has a high level of profitability. In this respect, we have used an accounting ratio to evaluate the profitability position of a company and identify a profitable company over a loss-making one.
ALGN AAWW XOM SEDG MOMO 8035 TOELF TOELY
Lam Research recognized billings of more than $1 billion in April from memory customers, which added to the company's $2.6 billion in billings for memory customers in FY Q3.
LRCX SSNLF HXSCF BC94 SMSN TOELY MU AMAT INTC 8035 TOELF HXSCL SMSD
The 225-issue Nikkei average gained 74.31 points, or 0.33 percent, to end at 22,878.35 on the Tokyo Stock Exchange. On Monday, the key market gauge climbed 109.54 points.
9020 8035 TOELF TOELY
Memory chip companies' semiconductor spend in 2017 grew 68% from 2016, which will result in capacity increases of 45% by the end of 2018.
LRCX SSNLF HXSCF MS.PRE MS.PRF MS.PRG MS.PRA TOELY MS.PRI MU MS.PRK AMAT MS 8035 TOELF HXSCL
TOKYO (Reuters) - Japan’s Nikkei share average rose to a one-week high on Monday morning, tracking Friday’s Wall Street’s gains after May jobs data pointed to strength in the U.S. economy, while a weaker yen lifted shares of Japanese exporters.
TM TYT TOYOF TOELY 25935 NDAQ TTDKF ITOEF 7203 ITONF 8035 TOELF 2593
Tokyo's benchmark Nikkei index rose Monday as geopolitical worries ebbed after US and North Korean officials met to resume preparations for a summit between the leaders of the two countries.
8035 TOELF TOELY
The benchmark Nikkei average edged up on the Tokyo Stock Exchange on Monday, with many investors refraining from active trading amid a dearth of fresh trading incentives.
JAPSY 8035 TOELF TOELY
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
as of ET